Moderna competitorsClear all

Moderna's top competitors include Celyad, CureVac, Regulus Therapeutics, Sarepta Therapeutics and Alnylam Pharmaceuticals.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Moderna
Moderna
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
CureVac
CureVac
CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.
Regulus Therapeutics
Regulus Therapeutics
Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Founding Date
Founding Date
N/A
Founding Date
2007
Founding Date
2000
Founding Date
2007
Founding Date
1980
Founding Date
2002
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Huddinge, SE
Cambridge, US
Norwood, US
Locations
Mont-Saint-Guibert, BE HQ
New York, US
Locations
Tübingen, DE HQ
Frankfurt Am Main, DE
Tübingen, DE
Boston, US
Locations
San Diego, US HQ
Locations
Cambridge, US HQ
Boulogne Billancourt, FR
Berlin, DE
Dublin, IE
Milano, IT
Chiyoda City, JP
see more
Locations
Cambridge, US HQ
Paris, FR
Milano, IT
Amsterdam, NL
Stockholm, SE
Zug, CH
Maidenhead, GB
Employees
Employees
8309% increase
Employees
8717% decrease
Employees
4004% increase
Employees
2462% decrease
Employees
74349% increase
Employees
1,32324% increase
Valuation ($)
Valuation ($)
140.1 b
Valuation ($)
70.6 m
Valuation ($)
1.5 b
Valuation ($)
54.9 m
Valuation ($)
5.5 b
Valuation ($)
21.4 b
Twitter followers
Twitter followers
111.7 k
Twitter followers
2.4 k
Twitter followers
5
Twitter followers
798
Twitter followers
3.6 k
Twitter followers
14.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
20
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
127.6
Average likes per tweet (last 30 days)
2.2
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
14.1
Average likes per tweet (last 30 days)
8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
72.73%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
51578
Alexa Website Rank
275697
Alexa Website Rank
307258
Alexa Website Rank
N/A
Alexa Website Rank
182573
Alexa Website Rank
365813
Employee Rating
Employee Rating
4.1
Employee Rating
3.7
Employee Rating
3.9
Employee Rating
2.8
Employee Rating
3.5
Employee Rating
4.4

Financial

Revenue (est.)
Revenue (est.)
$803.4m (FY, 2020)
Revenue (est.)
€3.5m (FY, 2017)
Revenue (est.)
€12.6m (FY, 2018)
Revenue (est.)
$10m (FY, 2020)
Revenue (est.)
$540.1m (FY, 2020)
Revenue (est.)
$492.9m (FY, 2020)
Cost of goods
Cost of goods
$7.9m (FY, 2020)
Cost of goods
€515k (FY, 2017)
Cost of goods
€22.3m (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$78.1m (FY, 2020)
Gross profit
Gross profit
$795.5m (FY, 2020)
Gross profit
€3m (FY, 2017)
Gross profit
(€9.8m) (FY, 2018)
Gross profit
N/A
Gross profit
N/A
Gross profit
$414.8m (FY, 2020)
Net income
Net income
($747.1m) (FY, 2020)
Net income
(€56.4m) (FY, 2017)
Net income
(€74.6m) (FY, 2018)
Net income
($15.7m) (FY, 2020)
Net income
($554.1m) (FY, 2020)
Net income
($858.3m) (FY, 2020)

Operating

Patent Applications
Patent Applications
250 (May, 2017)
Patent Applications
N/A
Patent Applications
500 (Mar, 2020)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patents Issued
Patents Issued
100 (Q3, 2018)
Patents Issued
N/A
Patents Issued
233 (May, 2020)
Patents Issued
300 (FY, 2016)
Patents Issued
N/A
Patents Issued
N/A

Funding

Total funding raised
Total funding raised
$ 1.8b
Total funding raised
N/A
Total funding raised
$ 1.1b
Total funding raised
$ 10m
Total funding raised
N/A
Total funding raised
$ 1.5b
For sources of this data, please see the company profile

View company profiles

Celyad
HQ
Mont-Saint-Guibert, BE
Employees
87↓ 17% decrease

Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.

View company
CureVac
HQ
Tübingen, DE
Employees
400↑ 4% increase

CureVac is a biotechnology company that is active in the field of messenger RNA (mRNA) technology.

View company
Regulus Therapeutics
HQ
San Diego, US
Employees
24

Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.

View company
Sarepta Therapeutics
HQ
Cambridge, US
Employees
743↑ 49% increase

Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.

View company